牛乳腺炎相关的专利数据

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
141	用于治疗奶牛乳腺炎和子宫内膜炎的含有苦豆子总碱的中药灌注液及其制备方法	CN201310079272.0	2013-03-12	CN103142683A	2013-06-12	周玉岩; 陶蕾; 梁剑平; 张志清; 逯佩凤; 代珍青
本发明公开了一种用于治疗奶牛病原性乳腺炎和子宫内膜炎，显效快、毒性低、易代谢、无残留的含有苦豆子总碱的中药灌注液，并提供了其制备方法。本发明的有益效果为：苦豆子总碱灌注液作为纯天然药物，具有毒副作用小，不易产生抗药性等优点，能显著的节省成本，减少弃奶损失，而且中药疗法注重调理，有利于机体整体机能和体况的恢复。此种含有苦豆子总碱的中药灌注液对于治疗奶牛乳腺炎具有广阔的发展前景。
142	一种检测奶牛乳腺炎的试剂盒及其使用方法	PCT/CN2020/112790	2020-09-01	WO2021057406A1	2021-04-01	吴萌; 魏治静; 李春生; 陈英珠
一种荧光免疫层析测定试剂盒及其使用方法，其中，该试剂盒包括塑料卡壳、检测试剂卡、样本稀释液，卡壳包括底壳和上盖，底壳内有试纸条卡槽，上盖设有扫描窗和样本加样孔；检测试剂卡由在底板上依次粘贴的样品垫、结合垫、硝酸纤维素膜和吸水纸组成；扫描窗的位置与硝酸纤维素膜的位置相配合，样本加样孔的位置与样品垫的位置相配合。该试剂盒通过检测牛奶中SAA的含量，判断奶牛是否患乳腺炎或乳腺炎的严重程度。
143	一种短棒状杆菌制剂或无细胞短棒状杆菌制剂在制备预防和治疗奶牛乳腺炎药剂中的应用	CN200910136044.6	2009-04-24	CN101869703A	2010-10-27	熊钧
本发明公开了一种短棒状杆菌制剂(CPP)或无细胞短棒状杆菌制剂(NCP)在制备预防和治疗牛乳腺炎药剂中的应用，所述短棒状杆菌制剂是由短棒状杆菌(CP)经灭活后制成的制剂，所述无细胞短棒状杆菌制剂是由短棒状杆菌(CP)经破碎后提取有效组分制成的制剂，该制剂颗粒大小较均一、吸收度明显提高，热原低；本发明的CPP与NCP可用于奶牛乳腺炎病的预防和治疗。
144	一种用于检测奶牛乳腺炎病原微生物及牛奶残留病原微生物的芯片	CN201520557060.3	2015-07-29	CN204939479U	2016-01-06	车团结; 胡巍; 徐进章; 张成虎; 魏锁成
本实用新型提供一种用于检测奶牛乳腺炎病原微生物及牛奶残留病原微生物的芯片，所述芯片包括芯片主体，所述芯片主体上有12个凹槽，分别为：Baird-Parker培养基凹槽，伊红美蓝培养基凹槽，BETA-SSA培养基凹槽，无乳链球菌显色培养基凹槽，B族链球菌培养基凹槽，克雷伯氏菌显色培养基凹槽，KF链球菌培养基凹槽，PALCAM培养基凹槽，沙门志贺菌属琼脂培养基凹槽，十六烷三甲基溴化铵琼脂培养基凹槽，沙保弱琼脂培养基凹槽，营养琼脂培养基凹槽。本实用新型的芯片能够同时检测引起奶牛乳腺炎的各种病原微生物以及牛奶残留的各种病原微生物，大大降低了检测人员的劳动强度，减少了培养基的消耗，降低了成本。
145	一种用于检测奶牛乳腺炎病原微生物耐药性的芯片	CN201520560720.3	2015-07-29	CN205011760U	2016-02-03	车团结; 胡巍; 徐进章; 张成虎; 魏锁成
本实用新型提供一种用于检测奶牛乳腺炎病原微生物耐药性的芯片，所述芯片包括芯片主体，所述芯片主体上有12个凹槽，分别为：庆大霉素MH培养基凹槽，左氧氟沙星MH培养基凹槽，环丙沙星MH培养基凹槽，青霉素MH培养基凹槽，头孢曲松拉MH培养基凹槽，四环素MH培养基凹槽，红霉素MH培养基凹槽，卡那霉素MH培养基凹槽，克林霉素MH培养基凹槽，氟哌酸MH培养基凹槽，先锋VMH培养基凹槽，去离子水MH培养基凹槽。本实用新型的芯片能够高通量检测奶牛乳腺炎病原微生物及牛奶残留病原微生物的耐药性，大大降低了检测人员的劳动强度，减少了培养基的消耗，降低了成本，使用也更加方便；检测结果能够用肉眼判断。
146	Treatment of mastitis in bovine udders	US438365	1974-01-31	US3950554A	1976-04-13	Emanuel C. Prince
Mastitis in bovine udders is treated and controlled by dipping the teats into a composition consisting essentially of a semi-drying oil and a fatty acid ester and allowing the teat to dry to form a water repellent film on the teat skin and across the teat orifice. The composition may also contain a bactericide, a healing agent, a hydration agent and a dye.
147	Bovine mastitis treatment	US547617	1995-10-24	US5846543A	1998-12-08	Mark A. Hassler; Lisa M. Hassler
Chemical compositions for the treatment of bovine mastitis which compositions are combinations of four components i.e.; Echinechea Goldenseal Supreme; Wild Ginseng Supreme; gelsemium, pokeroot, and aconite; and aloe vera juice, which form a dose which is injected into the mastitis affected portion of a cow's udder for a minimum of two doses per day for at least three days, which results in a cure for the mastitis.
148	Control of bovine mastitis	US615282	1975-09-22	US4025628A	1977-05-24	Lloyd G. Dewey; James J. Jezeski
A powdered, storage stable, effervescent formulation readily dispersible in water and containing a watersoluble chlorinated cyanurate, such as sodium dichloroisocyanurate, is mixed with water to provide a stable, slightly acid to neutral, non-irritating aqueous liquid having about 3,000 to 7,000 ppm titratable chlorine which is used as a teat dip for hygienic control of bovine mastitis.
149	QTLS FOR MASTITIS RESISTANCE IN CATTLE	EP07702476.8	2007-02-05	EP2069531B1	2013-04-10	LUND, Mogens, Sandø; BENDIXEN, Christian; SAHANA, Goutam; SØRENSEN, Peter; SVENDSEN, Søren; THOMSEN, Bo; MAJGREN, Bente, Flügel; SABRY, Ayman, Mahmoud; ANDERSSON-EKLUND, Ingrid, Lena; VILKKI, Helmi, Johanna; ISO-TOURU, Terhi, Katarlina; VIITALA, Sirja, Maria; SCHULMAN, Nina, Frederika; HASTINGS, Nicola; WILLIAMS, John, Lewis, William; WOOLLIAMS, John, Arthur; ÀVILA, Ana Isabel Fernández; VIINALASS, Haldja; VÅRV, Sirje

150	QTLS FOR MASTITIS RESISTANCE IN CATTLE	EP07702476.8	2007-02-05	EP2069531A2	2009-06-17	LUND, Mogens, Sandø; BENDIXEN, Christian; SAHANA, Goutam; SØRENSEN, Peter; SVENDSEN, Søren; THOMSEN, Bo; MAJGREN, Bente, Flügel; SABRY, Ayman, Mahmoud; ANDERSSON-EKLUND, Ingrid, Lena; VILKKI, Helmi, Johanna; ISO-TOURU, Terhi, Katarlina; VIITALA, Sirja, Maria; SCHULMAN, Nina, Frederika; HASTINGS, Nicola; WILLIAMS, John, Lewis, William; WOOLLIAMS, John, Arthur; ÀVILA, Ana Isabel Fernández; VIINALASS, Haldja; VÅRV. Sirje
The invention relates to a method for determining mastitis resistance in bovine subjects, wherein mastitis resistance comprise resistance to both sub-clinical and clinical mastitis. In particular, the method of the invention involves identification of genetic markers and/or Quantitative Trait Locus (QTL) for the determination of mastitis resistance in a bovine subject. The determination of mastitis resistance involves resolution of the specific microsatellite status. Furthermore, the invention relates to a diagnostic kit for detection of genetic marker(s) associated with mastitis resistance. The method and kit of the present invention can be applied for selection of bovine subjects for breeding purposes. Thus, the invention provides a method of genetically selecting bovine subjects with mastitis resistance, thereby yielding cows less prone to mastitis.
151	젓소의 유방염 검출회로	KR2019860007925	1986-06-04	KR2019890002682Y1	1989-04-29	송기춘; 오일환
내용 없음.
152	Qtls for Mastitis Resistance in Cattle	US12223689	2007-02-05	US20100003675A1	2010-01-07	Mogens Sando Lund; Bente Flugel Majgren; Goutam Sahana; Ayman Mahmoud Sabry; Peter Sorensen; Soren Svendsen; Bo Thomsen; Ingrid Lena Anderson-Eklund; Helmi Johanna Vilkki; Christian Bendixen; Terhi Katariina Iso-Touru; Sirja Maria Viitala; Nina Frederika Schulman; Nicola Hastings; John Lewis William Williams; John Arthur Woolliams; Ana Isabel Fernandez Avila; Haldja Viinalass; Sirje Varv
The invention relates to a method for determining mastitis resistance in bovine subjects, wherein mastitis resistance comprise resistance to both sub-clinical and clinical mastitis. In particular, the method of the invention involves identification of genetic markers and/or Quantitative Trait Locus (QTL) for the determination of mastitis resistance in a bovine subject. The determination of mastitis resistance involves resolution of the specific microsatellite status. Furthermore, the invention relates to a diagnostic kit for detection of genetic marker(s) associated with mastitis resistance. The method and kit of the present invention can be applied for selection of bovine subjects for breeding purposes. Thus, the invention provides a method of genetically selecting bovine subjects with mastitis resistance, thereby yielding cows less prone to mastitis.
153	Method of prophylaxis for bovine mastitis	US09873633	2001-06-04	US06537577B1	2003-03-25	Gregg Andrew Siegel
A method is provided for treating bovine mastitis by applying a porous strippable polymer film containing a medicament to the udders of the bovine.
154	Method of treating bovine mastitis	US58368656	1956-05-09	US2908609A	1959-10-13	ATERNO JOSEPH P; LUTHER HERBERT G; HAWLEY GAIL E; SACCHI EDWARD M

155	Mastitis detector for dairy cattle	US959536	1992-10-13	US5302903A	1994-04-12	Hendrik J. De Jong; Albertino B. M. Verstege; Pieter H. Hogewerf
A throughflow type mastitis detector having an inlet stub and an outlet stub by means of which the mastitis detector can be coupled to a milk tube; a measuring chamber having side walls, a closed bottom, and an opening opposite said bottom in spaced relationship to said inlet stub, through which opening the milk to be monitored, supplied through the inlet stub, can flow into the measuring chamber, and through which the milk can again leave the measuring chamber when the level of the milk within the measuring chamber exceeds the height of the lowest side wall portion; and a pair of electrodes in the bottom of said measuring chamber for measuring the electrical conductivity of the milk, characterized in that at least one of the electrodes has a convex head projecting above the bottom surface and a shank extending through an opening in the bottom.
156	Method for combatting bovine mastitis	US596203	1996-02-16	US5710124A	1998-01-20	John Edmondson Peel; Bruno Suri
A method for treating or preventing mastitis in cows is disclosed. The method contemplates the intramammary injection or dipping the teat with Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts. Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts can be administered prior to infection to effectively suppress the rate, severity, and duration of subsequent bacterial infection, or can be administered subsequent to infection to effectively treat mastitis.
157	Method of treating bovine masititis	US33566564	1964-01-03	US3347743A	1967-10-17	REUTER GERALD L; HILL GEORGE N

158	Method of detecting mastitis in cows	US620157	1984-06-13	US4659656A	1987-04-21	Markus Sandholm
There is disclosed a method for the quantitative determination of mastitis in a cow. This method comprises decaseinating and delipidating a milk sample from the cow to obtain a clear solution, substantially removing .alpha..sub.2 -macroglobulin from the sample, mixing the clear and substantially .alpha..sub.2 -macroglobulin free sample with a known amount to trypsin, and measuring the activity of the amount of trypsin which is in excess of the amount which is inactivated by the milk's antitrypsin.
159	젖소 유방염 치료용 조성물	KR1020100011967	2010-02-09	KR101156082B1	2012-06-20	심승규; 김동건; 황용배; 김영희
본 발명은 정제봉독, 키토산 및 프로폴리스를 포함하는 젖소 유방염 치료용 조성물에 관한 것으로서, 상기 조성물은 상용봉독, 키토산 또는 프로폴리스 단독에 비해 상승된 효과를 나타내므로, 젖소 유방염 치료에 유용하게 사용될 수 있다.
160	COMPOUNDS FOR TREATMENT OF BOVINE MASTITIS	EP11793310.1	2011-06-13	EP2579863A2	2013-04-17	HAFKIN, Barry
Described herein are methods of treating mastitis in female mammals, e.g., cows, wherein the methods may include administering to mammals in need thereof compounds disclosed herein.

3 4 5 6 7 8 9 10 11 12

IPRDB

热门服务

关于我们

友情链接

联系方式